24 results
8-K
EX-1.1
KYMR
Kymera Therapeutics Inc
5 Jan 24
Kymera Therapeutics Announces Proposed Public Offering
4:11pm
that the foregoing precludes the undersigned from engaging in any hedging or other transactions designed or intended, or which could reasonably be expected … . The undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transaction designed
424B5
KYMR
Kymera Therapeutics Inc
5 Jan 24
Prospectus supplement for primary offering
4:02pm
from engaging in any hedging or other transaction designed or intended, or which could reasonably be expected to lead to or result in, a sale … and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage
424B5
r4uq gv1wqtrf4
4 Jan 24
Prospectus supplement for primary offering
4:06pm
424B3
phut9kgnuqas2odf7x
6 Sep 22
Prospectus supplement
4:07pm
8-K
EX-10.1
3yh436
19 Aug 22
Kymera Announces $150 Million Private Placement Equity Financing
7:59am
424B4
fonsxbsc67odagp2
2 Jul 21
Prospectus supplement with pricing info
4:09pm
DEF 14A
m1l4 bo1wpuk
30 Apr 21
Definitive proxy
8:30am
DRS
6mf gtwxt5
17 Mar 21
Draft registration statement
12:00am
10-K
al4lgomg
11 Mar 21
Annual report
7:19am
10-Q
ikg7zp94xg722wtpz
5 Nov 20
Quarterly report
7:31am
8-K
EX-3.2
h483f
25 Aug 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B4
n1zn3sxt e7vihlp
21 Aug 20
Prospectus supplement with pricing info
5:19pm